Chronic heart failure is one of the most prevalent and life-threatening cardiovascular conditions worldwide. Among its various complications, iron deficiency anemia plays a crucial role in worsening patients’ overall condition, reducing exercise tolerance, and increasing fatigue. This study aims to investigate the prevalence of iron deficiency anemia in patients with chronic heart failure, evaluate its clinical manifestations, and explore laboratory parameters for early detection. The research highlights the significance of timely diagnosis and appropriate management of iron deficiency to improve functional capacity, quality of life, and treatment outcomes in affected patients. Modern diagnostic markers, including ferritin, transferrin saturation, and hepcidin, are emphasized as valuable tools for accurate assessment, while parenteral iron therapy is recognized for its effectiveness in clinical improvement. Understanding the interaction between chronic heart failure and iron deficiency anemia is essential for optimizing patient care and developing targeted therapeutic strategies.

Chronic heart failure, iron deficiency anemia, ferritin, transferrin saturation, hepcidin, parenteral iron therapy, functional capacity, quality of life, laboratory diagnostics, treatment outcomes.

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., ... & Seferovic, P. M. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 3599–3726.

Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., ... & Ponikowski, P. (2009). Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal of Medicine, 361(25), 2436–2448.

Ponikowski, P., van Veldhuisen, D. J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., ... & Anker, S. D. (2015). Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal, 36(11), 657–668.

Klip, I. T., Comin-Colet, J., Voors, A. A., Ponikowski, P., Enjuanes, C., Banasiak, W., ... & Anker, S. D. (2013). Iron deficiency in chronic heart failure: an international pooled analysis. American Heart Journal, 165(4), 575–582.

Camaschella, C. (2015). Iron-deficiency anemia. New England Journal of Medicine, 372(19), 1832–1843. https://doi.org/10.1056/NEJMra1401038

van der Meer, P., & Voors, A. A. (2019). Iron deficiency in heart failure: diagnosis and treatment. Heart, 105(5), 322–328.